[go: up one dir, main page]

CN110237304A - A kind of multi-level structure support and preparation method thereof - Google Patents

A kind of multi-level structure support and preparation method thereof Download PDF

Info

Publication number
CN110237304A
CN110237304A CN201910563578.0A CN201910563578A CN110237304A CN 110237304 A CN110237304 A CN 110237304A CN 201910563578 A CN201910563578 A CN 201910563578A CN 110237304 A CN110237304 A CN 110237304A
Authority
CN
China
Prior art keywords
preparation
spinning solution
extracellular matrix
natural source
multilevel structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910563578.0A
Other languages
Chinese (zh)
Inventor
赵金忠
朱同贺
蒋佳
燕晓宇
皇甫小桥
董士奎
徐才祺
谢国明
赵松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Sixth Peoples Hospital
Original Assignee
Shanghai Sixth Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Sixth Peoples Hospital filed Critical Shanghai Sixth Peoples Hospital
Priority to CN201910563578.0A priority Critical patent/CN110237304A/en
Publication of CN110237304A publication Critical patent/CN110237304A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633Extracellular matrix [ECM]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624Nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/10Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

The present invention relates to a kind of multilevel structure brackets and preparation method thereof, comprising the following steps: step 1 obtains natural source extracellular matrix;Step 2, the first spinning solution of preparation and the second spinning solution;Step 3, the first composite nano fibre yarn line of preparation;Step 4, preparation are in the mechanics enhancement layer of planar structure;Step 5, preparation are in the form of a column the substrate holder of structure;Step 6 makes to prepare multilevel structure bracket.It the advantage is that, use natural source extracellular matrix extract as electrospun material, sticking, be proliferated and migrating with good facilitation to cell be conducive to host cell and quickly cover with tough belt supporting frame, realize rapid regeneration;High molecular material can play the role of supporting newborn ligament tissue after the degradation of natural source extracellular matrix extract;The inside and outside of multilevel structure bracket is coated with composite nanometer particle gel, can guide, promote the fast-growth of osteocyte, to quickly rebuild tendon-bone.

Description

一种多级结构支架及其制备方法A kind of multi-level structure support and preparation method thereof

技术领域technical field

本发明涉及修复支架技术领域,尤其涉及一种多级结构支架及其制备方法。The invention relates to the technical field of repair brackets, in particular to a multi-level structure bracket and a preparation method thereof.

背景技术Background technique

膝关节是全身承载运动量最大、结构最复杂的关节,其结构、力学等特征使之易于损伤。前交叉韧带(Anterior Cruciate Ligaments,ACL)是最常见的受损部位之一,据统计美国ACL重建手术约30万例/年,我国ACL损伤病例保守估计至少60万例/年,对相关修复重建器械需求巨大。ACL损伤后缺乏自身再生修复能力,采用自体肌腱移植,仍是当今临床治疗的首选,但存在移植物来源受限、供区受损等局限。The knee joint is the joint with the largest amount of motion and the most complex structure in the whole body. Its structural and mechanical characteristics make it prone to injury. Anterior Cruciate Ligaments (ACL) is one of the most common damaged parts. According to statistics, there are about 300,000 ACL reconstruction operations per year in the United States, and a conservative estimate of at least 600,000 ACL injuries per year in my country. Equipment is in great demand. After ACL injury, it lacks self-regeneration and repair ability, so autologous tendon transplantation is still the first choice for clinical treatment today, but there are limitations such as limited source of graft and damaged donor site.

在现有的治疗方法中,常用的异体肌腱和人工合成韧带,但是这两种均存在一定缺陷。异体肌腱难以满足临床的需求量且存在传播传染性疾病的风险;人工合成韧带则存在无法诱导韧带再生、不能实现生理性腱-骨愈合、容易失效等缺陷。因此,临床迫切需求可诱导韧带再生的人工韧带植入器械。In the existing treatment methods, allogeneic tendons and artificial synthetic ligaments are commonly used, but both of them have certain defects. Allogeneic tendons are difficult to meet clinical needs and have the risk of spreading infectious diseases; artificial synthetic ligaments have defects such as inability to induce ligament regeneration, failure to achieve physiological tendon-bone healing, and easy failure. Therefore, there is an urgent clinical need for artificial ligament implantation devices that can induce ligament regeneration.

天然源细胞外基质提取物是广泛应用于组织工程支架中的一种组织再生诱导材料,其有效成分是胶原蛋白和弹性蛋白,为人体所具有的天然材料成分。利用静电纺丝技术制备的纳米纤维支架虽然会有一定的力学性能,但由于具有太小的孔隙,宿主细胞无法正常向纳米纤维内部迁移长入,仅仅通过物理黏附很难达到新生组织的快速重建,这就需要通过编织技术和热致相分离技术结合静电纺丝技术,分模块功能化赋予韧带支架,使其具有多层结构,各司其职,达到临床移植要求。Natural source extracellular matrix extract is a tissue regeneration inducing material widely used in tissue engineering scaffolds. Its active ingredients are collagen and elastin, which are natural material components of the human body. Although the nanofiber scaffold prepared by electrospinning technology has certain mechanical properties, due to the small pores, the host cells cannot normally migrate and grow into the nanofiber, and it is difficult to achieve rapid reconstruction of new tissue only through physical adhesion. , which requires the combination of weaving technology and thermal phase separation technology combined with electrospinning technology to functionalize the ligament scaffold in modules, so that it has a multi-layer structure, and each performs its duties to meet the requirements of clinical transplantation.

静电纺丝技术被广泛应用于制备组织工程支架,而编织技术被应用与制备韧带修复支架的报道也已有文献报道。由于热致相分离技术在制备纳米纤维时,可选择的材料有限制,虽不如前两者那么广泛应用,但与其他材料共混制备支架领域也有好很好的应用。但迄今为止,采用静电纺丝技术、编织技术和热致相分离技术结合的方法制备韧带修复支架的报道却尚未出现。Electrospinning technology is widely used in the preparation of tissue engineering scaffolds, and the application of weaving technology in the preparation of ligament repair scaffolds has also been reported in the literature. Since the thermally induced phase separation technology is limited in the choice of materials for the preparation of nanofibers, although it is not as widely used as the former two, it is also very good in the field of scaffolds prepared by blending with other materials. However, so far, there have been no reports on the preparation of ligament repair scaffolds by combining electrospinning technology, weaving technology and thermal phase separation technology.

因此,亟需一种利用静电纺丝技术、编织技术和热致相分离技术制备形成的用于韧带修复的支架,具有集力学性能和生物相容性于一体的优点。Therefore, there is an urgent need for a scaffold for ligament repair prepared by electrospinning technology, braiding technology and thermal phase separation technology, which has the advantages of integrating mechanical properties and biocompatibility.

发明内容Contents of the invention

本发明的目的是针对现有技术中的不足,提供一种多级结构支架及其制备方法。The object of the present invention is to provide a multi-level structure support and a preparation method thereof in view of the deficiencies in the prior art.

本发明的一个方面是,提供一种多级结构支架的制备方法,包括以下步骤:One aspect of the present invention is to provide a method for preparing a multi-level structure support, comprising the following steps:

步骤1、获取天然源细胞外基质,冷冻干燥处理后于4℃~-80℃下保存;Step 1. Obtain natural source extracellular matrix, freeze-dry and store at 4°C to -80°C;

步骤2、使用溶剂将所述天然源细胞外基质与高分子材料溶解,得到澄清的第一纺丝溶液和第二纺丝溶液;Step 2, using a solvent to dissolve the natural source extracellular matrix and the polymer material to obtain a clarified first spinning solution and a second spinning solution;

步骤3、使用所述第一纺丝溶液进行静电纺丝,以制备第一复合纳米纤维纱线;Step 3, using the first spinning solution to perform electrospinning to prepare the first composite nanofiber yarn;

步骤4、使用所述第一复合纳米纤维纱线制备呈平面结构的力学增强层;Step 4, using the first composite nanofiber yarn to prepare a mechanical reinforcement layer with a planar structure;

步骤5、在所述力学增强层的正面和反面涂覆复合纳米颗粒凝胶以形成凝胶层,再进行裹卷、热致相分离处理,得到呈柱状结构的第一支架;Step 5, coating composite nanoparticle gel on the front and back of the mechanically enhanced layer to form a gel layer, and then performing wrapping and thermally induced phase separation to obtain a first scaffold with a columnar structure;

步骤6、使用所述第二纺丝溶液进行静电纺丝,在所述第一支架的外表面覆盖一层所述第二复合纳米纤维以形成第二支架,以制备多级结构支架。Step 6. Electrospinning is performed using the second spinning solution, and a layer of the second composite nanofiber is covered on the outer surface of the first scaffold to form a second scaffold, so as to prepare a multi-level scaffold.

优选地,所述第一纺丝溶液和所述第二纺丝溶液的各组分含量相同或不同。Preferably, the content of each component of the first spinning solution and the second spinning solution is the same or different.

优选地,在步骤1中,获取所述天然源细胞外基质的方法为:Preferably, in step 1, the method for obtaining the natural source extracellular matrix is:

对猪尾或鼠尾或蚕蛹依次进行清洗、粉碎、脱胶、透析、冷冻干燥处理,然后使用含有青霉素/链霉素双抗的磷酸盐缓冲液喷洗若干次,以获取所述天然源细胞外基质。Washing, crushing, degumming, dialysis, and freeze-drying of pigtails or rat tails or silkworm chrysalis in sequence, and then spraying several times with phosphate buffer containing penicillin/streptomycin double antibodies to obtain the natural source extracellular matrix .

优选地,所述高分子材料为聚-4-羟基丁酸酯、3-羟基丁酸酯和3-羟基戊酸酯的共聚物、聚羟基脂肪酸酯、聚乳酸和聚己内酯的共聚物、聚对二氧环己酮、聚乳酸-羟基乙酸共聚物、生物医用可降解聚氨酯中的任意一种或几种的组合。Preferably, the polymer material is poly-4-hydroxybutyrate, a copolymer of 3-hydroxybutyrate and 3-hydroxyvalerate, a copolymer of polyhydroxyalkanoate, polylactic acid and polycaprolactone Any one or a combination of polydioxanone, poly(lactic-co-glycolic acid) and biomedical degradable polyurethane.

优选地,所述溶剂为六氟异丙醇、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、四氢呋喃、二氯甲烷、丙酮、氯仿、三氟乙酸、三氟乙醇中的任意一种或几种的组合。Preferably, the solvent is hexafluoroisopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran, dichloromethane, acetone, chloroform, trifluoroacetic acid, trifluoroethanol any one or a combination of several.

优选地,在所述步骤2中,所述第一纺丝溶液的各组分的重量份数如下:Preferably, in the step 2, the parts by weight of the components of the first spinning solution are as follows:

天然源细胞外基质提取物 5~50份Natural source extracellular matrix extract 5-50 parts

高分子材料 50~95份Polymer material 50~95 parts

溶剂 100份。100 parts of solvent.

优选地,在所述步骤2中,所述第二纺丝溶液的各组分的重量份数如下;Preferably, in the step 2, the parts by weight of the components of the second spinning solution are as follows;

天然源细胞外基质提取物 50~95份Natural source extracellular matrix extract 50-95 parts

高分子材料 5~50份Polymer material 5-50 parts

溶剂 100份。100 parts of solvent.

优选地,Preferably,

所述复合纳米颗粒凝胶由以下重量份的组分构成:The composite nanoparticle gel is composed of the following components by weight:

优选地,所述治疗因子为BMP-2、去铁胺、KGN、VEGF、地塞米松、丁香酚、硫酸软骨素、白介素中的任意一种或几种的组合。Preferably, the therapeutic factor is any one or a combination of several of BMP-2, deferoxamine, KGN, VEGF, dexamethasone, eugenol, chondroitin sulfate, and interleukin.

优选地,所述水为超纯水。Preferably, the water is ultrapure water.

优选地,在所述第一复合纳米纤维纱线中,纳米纤维沿所述第一复合纳米纤维纱线的轴向倾斜10°~80°。Preferably, in the first composite nanofiber yarn, the nanofibers are inclined by 10°-80° along the axial direction of the first composite nanofiber yarn.

优选地,在所述步骤2中,所述第一纺丝溶液和所述第二纺丝溶液的制备方法为:Preferably, in the step 2, the preparation method of the first spinning solution and the second spinning solution is:

步骤21、分别称取一定重量份数的所述天然源细胞外基质提取物和所述高分子材料;Step 21. Weighing certain parts by weight of the natural extracellular matrix extract and the polymer material;

步骤22、在50℃~80℃条件下,将所述天然源细胞外基质和所述高分子材料溶于所述溶剂中,搅拌溶解,以获得澄清的所述第一纺丝溶液和所述第二纺丝溶液;Step 22. Under the condition of 50°C-80°C, dissolve the natural source extracellular matrix and the polymer material in the solvent, and stir to dissolve, so as to obtain the clarified first spinning solution and the the second spinning solution;

其中,所述第一纺丝溶液和所述第二纺丝溶液的质量体积比为2%~30%。Wherein, the mass volume ratio of the first spinning solution to the second spinning solution is 2%-30%.

优选地,在所述步骤4中,使用并线、加捻、机织的方式将所述第一复合纳米纤维纱线制备成所述力学增强层。Preferably, in the step 4, the first composite nanofiber yarn is prepared into the mechanical reinforcement layer by means of doubling, twisting and weaving.

优选地,在所述步骤4中,使用并线、加捻、编织的方式将所述第一复合纳米纤维纱线制备成所述力学增强层。Preferably, in the step 4, the first composite nanofiber yarn is prepared into the mechanical reinforcement layer by means of doubling, twisting and weaving.

优选地,在所述步骤4中,使用并线、加捻针织的方式将所述第一复合纳米纤维制备成所述力学增强层。Preferably, in the step 4, the first composite nanofiber is prepared into the mechanical reinforcement layer by means of doubling and twisting knitting.

优选地,所述第一复合纳米纤维纱线含有加强芯层或不含有加强芯层。Preferably, the first composite nanofiber yarn contains a reinforcing core layer or does not contain a reinforcing core layer.

优选地,所述加强芯层为聚-4-羟基丁酸酯、3-羟基丁酸酯和3-羟基戊酸酯的共聚物、聚羟基脂肪酸酯、聚乳酸和聚己内酯的共聚物、聚对二氧环己酮、聚乳酸-羟基乙酸共聚物、生物医用可降解聚氨酯中的任意一种或几种的组合制成。Preferably, the reinforcing core layer is poly-4-hydroxybutyrate, a copolymer of 3-hydroxybutyrate and 3-hydroxyvalerate, a copolymer of polyhydroxyalkanoate, polylactic acid and polycaprolactone It is made of any one or a combination of polydioxanone, polylactic acid-glycolic acid copolymer, and biomedical degradable polyurethane.

优选地,所述加强芯层的制备方法为:Preferably, the preparation method of the reinforced core layer is:

通过熔融拉丝制备直径为50μm~300μm的单丝;Preparation of monofilaments with a diameter of 50 μm to 300 μm by melt drawing;

将4~8根单丝为一股,2~10股进行加捻处理后得到加强芯层。4-8 monofilaments are divided into one strand, and 2-10 strands are twisted to obtain a reinforced core layer.

本发明的另一个方面是,提供一种由上述制备方法制得的多级结构支架。Another aspect of the present invention is to provide a multi-level structure scaffold prepared by the above preparation method.

本发明采用以上技术方案,与现有技术相比,具有如下技术效果:The present invention adopts the above technical scheme, and compared with the prior art, it has the following technical effects:

本发明的一种多级结构支架及其制备方法,使用天然源细胞外基质提取物作为静电纺丝材料,对细胞的黏附、增殖和迁移具有良好的促进作用,有利于宿主细胞快速长满韧带支架,实现快速再生;高分子材料能够在天然源细胞外基质提取物降解后起到支撑新生韧带组织的作用;多级结构支架的内外均涂覆有复合纳米颗粒凝胶,能够引导、促进骨细胞的快速生长,从而快速重建腱-骨。A multi-level structure scaffold and its preparation method of the present invention uses natural source extracellular matrix extract as the electrospinning material, which has a good promoting effect on cell adhesion, proliferation and migration, and is conducive to the rapid growth of host cells with ligaments scaffold to achieve rapid regeneration; polymer materials can support the new ligament tissue after the degradation of natural extracellular matrix extracts; the inside and outside of the multi-level structure scaffold are coated with composite nanoparticle gel, which can guide and promote bone regeneration Rapid growth of cells, thereby rapidly rebuilding tendon-bone.

附图说明Description of drawings

图1为本发明的多级结构支架的制备过程示意图。Fig. 1 is a schematic diagram of the preparation process of the multi-level structure scaffold of the present invention.

图2a为本发明的第一复合纳米纤维纱线的示意图。Figure 2a is a schematic diagram of a first composite nanofiber yarn of the present invention.

图2b为本发明的第一复合纳米纤维纱线的扫描电子显微镜图。Figure 2b is a scanning electron microscope image of the first composite nanofiber yarn of the present invention.

图3a为本发明的复合纳米颗粒凝胶的示意图。Figure 3a is a schematic diagram of the composite nanoparticle gel of the present invention.

图3b为本发明的复合纳米颗粒凝胶的透射电子显微镜图。Fig. 3b is a transmission electron microscope image of the composite nanoparticle gel of the present invention.

图4a为本发明的涂覆有复合纳米颗粒凝胶的多级结构支架的扫描电子显微镜图Fig. 4a is the scanning electron micrograph of the hierarchical structure scaffold coated with composite nanoparticle gel of the present invention

图4b为本发明的涂覆有复合纳米颗粒凝胶的多级节后支架的断面的扫描电子显微镜图。Fig. 4b is a scanning electron microscope image of a section of the multi-level postganglionic scaffold coated with composite nanoparticle gel of the present invention.

图5为本发明的一个示意性实施例的多级结构支架的示意图。Fig. 5 is a schematic diagram of a multi-level structural support according to an exemplary embodiment of the present invention.

图6为本发明的一个示意性实施例的多级结构支架的剖面图。Fig. 6 is a cross-sectional view of a multi-level structural support according to an exemplary embodiment of the present invention.

其中的附图标记为:第一支架100;凝胶层200;第二支架300。The reference signs therein are: the first support 100 ; the gel layer 200 ; the second support 300 .

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动的前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

需要说明的是,在不冲突的情况下,本发明中的实施例及实施例中的特征可以相互组合。It should be noted that, in the case of no conflict, the embodiments of the present invention and the features in the embodiments can be combined with each other.

下面结合附图和具体实施例对本发明作进一步说明,但不作为本发明的限定。The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments, but not as a limitation of the present invention.

实施例1Example 1

本发明的一个示意性实施例,如图1~6所示,一种多级结构支架的制备方法,包括以下步骤:A schematic embodiment of the present invention, as shown in Figures 1 to 6, a method for preparing a multi-level structure scaffold, comprising the following steps:

步骤1、获取天然源细胞外基质,冷冻干燥处理后于4℃~-80℃下保存;Step 1. Obtain natural source extracellular matrix, freeze-dry and store at 4°C to -80°C;

步骤2、使用溶剂将天然源细胞外基质与高分子材料溶解,得到澄清的第一纺丝溶液和第二纺丝溶液;Step 2, using a solvent to dissolve the natural source extracellular matrix and the polymer material to obtain a clarified first spinning solution and a second spinning solution;

步骤3、使用第一纺丝溶液进行喇叭-共轭静电纺丝,以制备第一复合纳米纤维纱线;Step 3, using the first spinning solution to perform trumpet-conjugated electrospinning to prepare the first composite nanofiber yarn;

步骤4、使用第一复合纳米纤维纱线制备呈平面结构的力学增强层;Step 4, using the first composite nanofiber yarn to prepare a mechanical reinforcement layer with a planar structure;

步骤5、在力学增强层的正面和反面涂覆复合纳米颗粒凝胶以形成凝胶层200,再进行裹卷、热致相分离处理,得到呈柱状结构的第一支架100;Step 5. Coating composite nanoparticle gel on the front and back of the mechanically enhanced layer to form a gel layer 200, and then performing wrapping and thermal phase separation treatment to obtain the first columnar structure 100;

步骤6、使用第二纺丝溶液进行喇叭-共轭静电纺丝,在第一支架100的外表面覆盖一层第二复合纳米纤维以形成第二支架300,以制备多级结构支架。Step 6. Use the second spinning solution to perform trumpet-conjugated electrospinning, and cover the outer surface of the first scaffold 100 with a layer of second composite nanofibers to form the second scaffold 300 to prepare a multi-level scaffold.

进一步地,在步骤1中,获取天然源细胞外基质的方法为:Further, in step 1, the method for obtaining natural source extracellular matrix is:

对猪尾或鼠尾或蚕蛹依次进行清洗、粉碎、脱胶、透析、冷冻干燥处理,然后使用含有青霉素/链霉素双抗的磷酸盐缓冲液喷洗若干次,以获取天然源细胞外基质。Pig tail or rat tail or silkworm chrysalis are washed, pulverized, degummed, dialyzed, freeze-dried sequentially, and then sprayed with phosphate buffer containing penicillin/streptomycin double antibody several times to obtain natural extracellular matrix.

其中,猪尾取自3个月大的健康动物、鼠尾取自4个星期大的健康动物、蚕蛹为柞蚕蚕蛹。Among them, pigtails were taken from 3-month-old healthy animals, rat tails were taken from 4-week-old healthy animals, and silkworm chrysalis were tussah silkworm chrysalis.

进一步地,使用含有0.5%~1%青霉素/链霉素双抗的磷酸盐缓冲液喷洗10~20次。Further, spray wash 10-20 times with phosphate buffer solution containing 0.5%-1% penicillin/streptomycin double antibody.

进一步地,高分子材料为聚-4-羟基丁酸酯、3-羟基丁酸酯和3-羟基戊酸酯的共聚物、聚羟基脂肪酸酯、聚乳酸和聚己内酯的共聚物、聚对二氧环己酮、聚乳酸-羟基乙酸共聚物、生物医学聚氨酯中的任意一种或几种的组合。Further, the polymer material is poly-4-hydroxybutyrate, a copolymer of 3-hydroxybutyrate and 3-hydroxyvalerate, a copolymer of polyhydroxyalkanoate, polylactic acid and polycaprolactone, Any one or a combination of polydioxanone, poly(lactic-co-glycolic acid) and biomedical polyurethane.

进一步地,溶剂为六氟异丙醇、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、四氢呋喃、二氯甲烷、丙酮、氯仿、三氟乙酸、三氟乙醇中的任意一种或几种的组合。Further, the solvent is hexafluoroisopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran, dichloromethane, acetone, chloroform, trifluoroacetic acid, trifluoroethanol Any one or combination of several.

进一步地,在步骤2中,第一纺丝溶液的各组分的重量份数如下:Further, in step 2, the parts by weight of the components of the first spinning solution are as follows:

天然源细胞外基质提取物 5~50份Natural source extracellular matrix extract 5-50 parts

高分子材料 50~95份Polymer material 50~95 parts

溶剂 100份。100 parts of solvent.

进一步地,在步骤2中,第二纺丝溶液的各组分的重量份数如下;Further, in step 2, the parts by weight of the components of the second spinning solution are as follows;

天然源细胞外基质提取物 50~95份Natural source extracellular matrix extract 50-95 parts

高分子材料 5~50份Polymer material 5-50 parts

溶剂 100份。100 parts of solvent.

进一步地,further,

复合纳米颗粒凝胶由以下重量份的组分构成:The composite nanoparticle gel consists of the following components by weight:

进一步地,治疗因子为BMP-2、去铁胺、KGN、VEGF、地塞米松、丁香酚、硫酸软骨素、白介素中的任意一种或几种的组合。Further, the therapeutic factor is any one or a combination of BMP-2, deferoxamine, KGN, VEGF, dexamethasone, eugenol, chondroitin sulfate, and interleukin.

进一步地,水为超纯水。Further, water is ultrapure water.

进一步地,在第一复合纳米纤维纱线中,其纳米纤维沿第一复合纳米纤维纱线的轴向倾斜10°~80°。Further, in the first composite nanofiber yarn, the nanofibers thereof are inclined by 10°-80° along the axial direction of the first composite nanofiber yarn.

进一步地,在步骤2中,第一纺丝溶液和第二纺丝溶液的制备方法为:Further, in step 2, the preparation method of the first spinning solution and the second spinning solution is:

步骤21、分别称取一定重量份数的天然源细胞外基质提取物和高分子材料;Step 21, weighing certain parts by weight of natural extracellular matrix extract and polymer material;

步骤22、在50℃~80℃条件下,将天然源细胞外基质和高分子材料溶于溶剂中,搅拌溶解,以获得澄清的第一纺丝溶液和第二纺丝溶液;Step 22, under the condition of 50°C to 80°C, dissolving the natural source extracellular matrix and the polymer material in the solvent, stirring and dissolving to obtain a clear first spinning solution and a second spinning solution;

其中,第一纺丝溶液和第二纺丝溶液的质量体积比为2%~30%。Wherein, the mass volume ratio of the first spinning solution and the second spinning solution is 2%-30%.

进一步地,制备第一复合纳米纤维纱线的方法为:Further, the method for preparing the first composite nanofiber yarn is:

将第一纺丝溶液分别与正负极针头连接,将高分子材料的加捻复丝(即纱线增强芯)穿过束线器,并预先缠绕在接收辊上,然后将正负极针头与高压电源连接进行静电纺丝,即可制得第一纳米纤维,将第一纳米纤维或第二纳米纤维缠绕在纱线增强芯上,即可制得第一复合纳米纤维纱线(如图2a-2b所示)。Connect the first spinning solution to the positive and negative needles respectively, pass the twisted multifilament of polymer material (that is, the yarn reinforcement core) through the beamer, and pre-wrap it on the receiving roller, and then connect the positive and negative needles Connect with a high-voltage power supply for electrospinning to obtain the first nanofiber, and wind the first nanofiber or the second nanofiber on the yarn reinforcing core to obtain the first composite nanofiber yarn (as shown in Fig. 2a-2b).

进一步地,在步骤4中,使用并线、加捻、机织的方式将第一复合纳米纤维纱线制备成力学增强层。Further, in step 4, the first composite nanofiber yarn is prepared into a mechanical reinforcement layer by means of doubling, twisting and weaving.

进一步地,在步骤4中,使用并线、加捻、编织的方式将第一复合纳米纤维纱线制备成力学增强层。Further, in step 4, the first composite nanofiber yarn is prepared into a mechanical reinforcement layer by means of doubling, twisting and weaving.

进一步地,在步骤4中,使用并线、加捻针织的方式将第一复合纳米纤维纱线制备成力学增强层。Further, in step 4, the first composite nanofiber yarn is prepared into a mechanical reinforcement layer by means of doubling and twisting knitting.

进一步地,复合纳米颗粒凝胶的制备方法为:Further, the preparation method of the composite nanoparticle gel is:

将促进骨细胞和肌腱细胞增殖、迁移的治疗因子通过物理吸附和化学接枝的方法负载在呈树状的无机纳米颗粒上,然后将负载治疗因子的纳米颗粒分散在以二甲基亚砜/水为溶剂的聚(酯-醚)型聚氨酯脲酯凝胶中,即可获得复合纳米颗粒凝胶(如图3a-3b所示)。Therapeutic factors that promote the proliferation and migration of bone cells and tenocytes are loaded on dendritic inorganic nanoparticles by physical adsorption and chemical grafting, and then the nanoparticles loaded with therapeutic factors are dispersed in dimethyl sulfoxide/ In the poly(ester-ether) polyurethane urea gel with water as the solvent, the composite nanoparticle gel can be obtained (as shown in Figures 3a-3b).

对于制备的多级结构支架,其中,第二支架300的高度小于第一支架100的高度。For the prepared multi-level structure bracket, the height of the second bracket 300 is smaller than the height of the first bracket 100 .

进一步地,第二支架300的两端与第一支架100的两端互不接触。Further, the two ends of the second bracket 300 are not in contact with the two ends of the first bracket 100 .

进一步地,第二支架300的第一端和第一支架100的第一端之间的距离与第二支架300的第二端与第一支架100的第二端之间的距离相等或不相等。Further, the distance between the first end of the second bracket 300 and the first end of the first bracket 100 is equal to or unequal to the distance between the second end of the second bracket 300 and the second end of the first bracket 100 .

实施例2Example 2

本实施例为本发明的一个具体实施例。This embodiment is a specific embodiment of the present invention.

本实施例的一种多级结构支架的制备方法,包括以下步骤:The preparation method of a kind of multi-level structure support of the present embodiment, comprises the following steps:

步骤1、对柞蚕蚕蛹依次进行清洗、粉碎、脱胶、透析、冷冻干燥处理,然后使用含有0.5%~1%青霉素/链霉素双抗的磷酸盐缓冲液喷洗10~20次,以获取柞蚕丝素蛋白作为天然源细胞外基质,冷冻干燥处理后于4℃~-80℃下保存;Step 1. Washing, pulverizing, degumming, dialysis, and freeze-drying the tussah silkworm chrysalis in sequence, and then spraying 10 to 20 times with phosphate buffer solution containing 0.5% to 1% penicillin/streptomycin double antibody to obtain tussah silkworm pupae Silk fibroin is used as a natural source of extracellular matrix, and it is stored at 4°C to -80°C after freeze-drying;

步骤2、制备纺丝溶液Step 2, preparation of spinning solution

步骤21、分别称取柞蚕丝素蛋白50重量份和聚乳酸和聚己内酯的共聚物50重量份;Step 21, weighing 50 parts by weight of tussah silk fibroin protein and 50 parts by weight of a copolymer of polylactic acid and polycaprolactone;

步骤22、在50℃水浴条件下,将柞蚕丝素蛋白和聚乳酸和聚己内酯的共聚物溶于六氟异丙醇中,搅拌溶解,以获得澄清的第一纺丝溶液和第二纺丝溶液;Step 22. Dissolve the copolymer of tussah silk fibroin, polylactic acid and polycaprolactone in hexafluoroisopropanol under the condition of a water bath at 50°C, and stir to dissolve to obtain a clear first spinning solution and a second clear spinning solution. spinning solution;

其中,第一纺丝溶液和第二纺丝溶液的质量体积比(g/mL)为10%;Wherein, the mass volume ratio (g/mL) of the first spinning solution and the second spinning solution is 10%;

步骤3、使用第一纺丝溶液进行喇叭-共轭静电纺丝,以制备第一复合纳米纤维纱线;Step 3, using the first spinning solution to perform trumpet-conjugated electrospinning to prepare the first composite nanofiber yarn;

步骤4、利用四股并线、加捻结合编织技术使用第一复合纳米纤维纱线制备呈平面结构的力学增强层;Step 4, using the four-ply doubling, twisting and weaving technology to use the first composite nanofiber yarn to prepare a mechanical reinforcement layer with a planar structure;

步骤5、在力学增强层的正面和反面涂覆复合纳米颗粒凝胶以形成凝胶层200,再进行裹卷至6.5mm,热致相分离处理,-80℃冷冻,然后冷冻干燥处理后,得到呈柱状结构的第一支架100;Step 5. Coating composite nanoparticle gel on the front and back of the mechanically enhanced layer to form a gel layer 200, then wrapping to 6.5mm, heat-induced phase separation treatment, freezing at -80°C, and then freeze-drying, Obtain the first support 100 in columnar structure;

其中,复合纳米颗粒凝胶为在有BMP-2/去铁胺纳米颗粒的聚(酯-醚)型聚氨酯脲酯凝胶;Wherein, the composite nanoparticle gel is a poly(ester-ether) polyurethane urethane gel with BMP-2/deferoxamine nanoparticles;

步骤6、使用第二纺丝溶液进行喇叭-共轭静电纺丝,在第一支架100的外表面覆盖一层第二复合纳米纤维以形成第二支架300,即可制得直径为6mm的多级结构支架。Step 6. Use the second spinning solution to perform trumpet-conjugated electrospinning, and cover the outer surface of the first support 100 with a layer of second composite nanofibers to form the second support 300, so that a polyamide with a diameter of 6 mm can be obtained. Level structure support.

实施例3Example 3

本实施例为本发明的一个具体实施例。This embodiment is a specific embodiment of the present invention.

本实施例的一种多级结构支架的制备方法,包括以下步骤:The preparation method of a kind of multi-level structure support of the present embodiment, comprises the following steps:

步骤1、对猪尾依次进行清洗、粉碎、脱胶、透析、冷冻干燥处理,然后使用含有0.5%~1%青霉素/链霉素双抗的磷酸盐缓冲液喷洗10~20次,以获取猪尾胶原蛋白作为天然源细胞外基质,冷冻干燥处理后于4℃~-80℃下保存;Step 1. Washing, pulverizing, degumming, dialysis, and freeze-drying the pigtail in sequence, and then spraying 10 to 20 times with phosphate buffer solution containing 0.5% to 1% penicillin/streptomycin double antibody to obtain pigtail collagen Protein is used as a natural source of extracellular matrix, and it is stored at 4°C to -80°C after freeze-drying;

步骤2、制备纺丝溶液Step 2, preparation of spinning solution

步骤21、分别称取猪尾胶原蛋白80重量份和聚对环氧二己酮20重量份作为制备第一纺丝溶液的组分;Step 21, respectively weighing 80 parts by weight of pigtail collagen and 20 parts by weight of poly(p-epoxide dihexanone) as components for preparing the first spinning solution;

分别称取猪尾胶原蛋白50重量份和聚对环氧二己酮50重量份作为制备第二纺丝溶液的组分Weigh respectively 50 parts by weight of pigtail collagen and 50 parts by weight of poly(p-epoxide dihexanone) as components for preparing the second spinning solution

步骤22、在30℃水浴条件下,将猪尾胶原蛋白和聚对环氧二己酮溶于四氢呋喃/二氯甲烷(体积比为75:25)中,搅拌溶解,以获得澄清的第一纺丝溶液和第二纺丝溶液;Step 22. Dissolve pigtail collagen and poly(p-epoxide dihexanone) in tetrahydrofuran/dichloromethane (volume ratio 75:25) in a water bath at 30°C, and stir to dissolve to obtain a clear first spinning solution and a second spinning solution;

其中,第一纺丝溶液和第二纺丝溶液的质量体积比(g/mL)为15%;Wherein, the mass volume ratio (g/mL) of the first spinning solution and the second spinning solution is 15%;

步骤3、使用第一纺丝溶液进行喇叭-共轭静电纺丝,以制备第一复合纳米纤维纱线;Step 3, using the first spinning solution to perform trumpet-conjugated electrospinning to prepare the first composite nanofiber yarn;

步骤4、利用四股并线、加捻结合编织技术使用第一复合纳米纤维纱线制备呈平面结构的力学增强层;Step 4, using the four-ply doubling, twisting and weaving technology to use the first composite nanofiber yarn to prepare a mechanical reinforcement layer with a planar structure;

步骤5、在力学增强层的正面和反面涂覆复合纳米颗粒凝胶以形成凝胶层200,再进行裹卷至4.3mm,热致相分离处理,-80℃冷冻,然后冷冻干燥处理后,得到呈柱状结构的第一支架100;Step 5. Coating composite nanoparticle gel on the front and back of the mechanically enhanced layer to form a gel layer 200, then wrapping to 4.3mm, heat-induced phase separation treatment, freezing at -80°C, and then freeze-drying, Obtain the first support 100 in columnar structure;

其中,复合纳米颗粒凝胶为在有BMP-2/去铁胺纳米颗粒的聚(酯-醚)型聚氨酯脲酯凝胶;Wherein, the composite nanoparticle gel is a poly(ester-ether) polyurethane urethane gel with BMP-2/deferoxamine nanoparticles;

步骤6、使用第二纺丝溶液进行喇叭-共轭静电纺丝,在第一支架100的外表面覆盖一层第二复合纳米纤维以形成第二支架300,即可制得直径为4mm的多级结构支架。Step 6. Use the second spinning solution to perform trumpet-conjugated electrospinning, and cover the outer surface of the first support 100 with a layer of second composite nanofibers to form the second support 300, so that a polyamide with a diameter of 4 mm can be obtained. Level structure support.

以上所述仅为本发明较佳的实施例,并非因此限制本发明的实施方式及保护范围,对于本领域技术人员而言,应当能够意识到凡运用本发明说明书及图示内容所作出的等同替换和显而易见的变化所得到的方案,均应当包含在本发明的保护范围内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the implementation and protection scope of the present invention. For those skilled in the art, they should be able to realize that all equivalents made by using the description and illustrations of the present invention The solutions obtained by replacement and obvious changes shall all be included in the protection scope of the present invention.

Claims (10)

1. a kind of preparation method of multilevel structure bracket, which comprises the following steps:
Step 1 obtains natural source extracellular matrix, saves at 4 DEG C~-80 DEG C after freeze-drying process;
Step 2 is dissolved the natural source extracellular matrix and high molecular material using solvent, and it is molten to obtain clear first spinning Liquid and the second spinning solution;
Step 3 carries out electrostatic spinning using first spinning solution, to prepare the first composite nano fibre yarn line;
Step 4 prepares the mechanics enhancement layer in planar structure using the first composite nano fibre yarn line;
Step 5, the mechanics enhancement layer obverse and reverse coating composite nanometer particle gel to form gel layer, then carry out Volume, Thermal inactive processing are wrapped up in, the first support for being in the form of a column structure is obtained;
Step 6 carries out loudspeaker-conjugation electrostatic spinning using second spinning solution, covers in the outer surface of the first support One layer of lid the second composite nano fibre yarn line is to form second support, to prepare multilevel structure bracket.
2. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that in step 1, described in acquisition The method of natural source extracellular matrix are as follows:
Pigtail or rat-tail or silkworm chrysalis are successively cleaned, crushed, degumming, dialysis, freeze-drying process, then using containing green The dual anti-phosphate buffer hydro-peening of mycin/streptomysin several times, to obtain the natural source extracellular matrix.
3. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that the high molecular material is Poly- 4 hydroxybutyric acid ester, the copolymer of 3-hydroxybutyrate ester and 3- hydroxyl valerate, polyhydroxyalkanoate, polylactic acid and poly- It is the copolymer of caprolactone, polydioxanone, poly lactide-glycolide acid, any one in biomedical polyurethane Kind or several combinations.
4. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that the solvent is hexafluoro isopropyl Alcohol, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide, tetrahydrofuran, methylene chloride, acetone, chloroform, trifluoroacetic acid, three Any one or the combination of several of them in fluoroethanol.
5. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that described in the step 2 The parts by weight of each component of first spinning solution are as follows:
5~50 parts of natural source extracellular matrix extract
50~95 parts of high molecular material
100 parts of solvent.
6. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that described in the step 2 The parts by weight of each component of second spinning solution are as follows;
50~95 parts of natural source extracellular matrix extract
5~50 parts of high molecular material
100 parts of solvent.
7. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that the composite nanometer particle is solidifying Glue consists of the following parts by weight:
8. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that in first composite Nano In fiber yarn, axially inclined 10 °~80 ° along the first composite nano fibre yarn line of nanofiber.
9. the preparation method of multilevel structure bracket according to claim 1, which is characterized in that described in the step 2 First spinning solution and second spinning solution the preparation method comprises the following steps:
Step 21, the natural source extracellular matrix extract and the high molecular material for weighing constant weight number respectively;
Step 22, under the conditions of 50 DEG C~80 DEG C, the natural source extracellular matrix and the high molecular material are dissolved in described In solvent, stirring and dissolving, to obtain clear first spinning solution and second spinning solution;
Wherein, the mass volume ratio of first spinning solution and second spinning solution is 2%~30%.
10. a kind of multilevel structure bracket is made by the preparation method of any multilevel structure bracket of claim 1~9.
CN201910563578.0A 2019-06-26 2019-06-26 A kind of multi-level structure support and preparation method thereof Pending CN110237304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910563578.0A CN110237304A (en) 2019-06-26 2019-06-26 A kind of multi-level structure support and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910563578.0A CN110237304A (en) 2019-06-26 2019-06-26 A kind of multi-level structure support and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110237304A true CN110237304A (en) 2019-09-17

Family

ID=67889773

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910563578.0A Pending CN110237304A (en) 2019-06-26 2019-06-26 A kind of multi-level structure support and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110237304A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111345920A (en) * 2020-03-11 2020-06-30 上海市第六人民医院 A kind of transitional structured textile-based scaffold for promoting tendon-bone healing and preparation method thereof
CN112870433A (en) * 2021-01-18 2021-06-01 华东理工大学 DFO and rhBMP-2 synergistically stimulated osteogenesis composite scaffold and preparation method and application thereof
CN114425101A (en) * 2022-01-21 2022-05-03 北京大学口腔医学院 Micro-nano double-layer structure antibacterial bracket and preparation method and application thereof
CN114732948A (en) * 2022-03-25 2022-07-12 上海工程技术大学 Rotator cuff patch and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103919629A (en) * 2014-04-18 2014-07-16 清华大学 Tough tissue structure and 3D printing forming device and method thereof
CN106390196A (en) * 2016-09-07 2017-02-15 东华大学 Preparation method of nanofiber nerve tissue engineering scaffold
CN107149699A (en) * 2016-03-03 2017-09-12 北京化工大学 A kind of neural tissue engineering conductive fiber tubular bracket and preparation method thereof
CN107530475A (en) * 2015-04-15 2018-01-02 新泽西州立拉特格斯大学 Biocompatible implant and its application method for nerve regneration
CN109009561A (en) * 2018-08-13 2018-12-18 哈尔滨工业大学(威海) A kind of artificial blood vessel and preparation method thereof
US20190054205A1 (en) * 2017-05-16 2019-02-21 Embody Llc Biopolymer compositions, scaffolds and devices

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103919629A (en) * 2014-04-18 2014-07-16 清华大学 Tough tissue structure and 3D printing forming device and method thereof
CN107530475A (en) * 2015-04-15 2018-01-02 新泽西州立拉特格斯大学 Biocompatible implant and its application method for nerve regneration
CN107149699A (en) * 2016-03-03 2017-09-12 北京化工大学 A kind of neural tissue engineering conductive fiber tubular bracket and preparation method thereof
CN106390196A (en) * 2016-09-07 2017-02-15 东华大学 Preparation method of nanofiber nerve tissue engineering scaffold
US20190054205A1 (en) * 2017-05-16 2019-02-21 Embody Llc Biopolymer compositions, scaffolds and devices
CN109009561A (en) * 2018-08-13 2018-12-18 哈尔滨工业大学(威海) A kind of artificial blood vessel and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
唐朝晖主编: "生命科学综合设计实验指南", 中国农业科技出版社, pages: 212 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111345920A (en) * 2020-03-11 2020-06-30 上海市第六人民医院 A kind of transitional structured textile-based scaffold for promoting tendon-bone healing and preparation method thereof
CN112870433A (en) * 2021-01-18 2021-06-01 华东理工大学 DFO and rhBMP-2 synergistically stimulated osteogenesis composite scaffold and preparation method and application thereof
CN114425101A (en) * 2022-01-21 2022-05-03 北京大学口腔医学院 Micro-nano double-layer structure antibacterial bracket and preparation method and application thereof
CN114425101B (en) * 2022-01-21 2022-07-22 北京大学口腔医学院 Micro-nano double-layer structure antibacterial bracket and preparation method and application thereof
CN114732948A (en) * 2022-03-25 2022-07-12 上海工程技术大学 Rotator cuff patch and preparation method thereof

Similar Documents

Publication Publication Date Title
Wu et al. Fibre‐based scaffolding techniques for tendon tissue engineering
EP3351376B1 (en) Silk biomaterials and methods of use thereof
Tang et al. Functional biomaterials for tendon/ligament repair and regeneration
CN110237304A (en) A kind of multi-level structure support and preparation method thereof
CN111450316B (en) Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure
EP2373354B1 (en) Tissue repair scaffold
Cai et al. Constructing high-strength nano-micro fibrous woven scaffolds with native-like anisotropic structure and immunoregulatory function for tendon repair and regeneration
US20130312638A1 (en) Systems, devices and methods for the fabrication of polymeric fibers
Reverchon et al. Biodegradable synthetic scaffolds for tendon regeneration
WO2004001103A2 (en) Silk biomaterials and methods of use thereof
CN110331486A (en) A kind of multilayered structure nano-fibre yams knitting tendon scaffold and its preparation and application
CN104998302B (en) It is a kind of using oriented nanofibers felt as nanometer cartilage repair material of skeleton and preparation method thereof
CN110384824A (en) A kind of three-stage functional form degradable artificial ligament regeneration support and preparation method thereof
Saatcioglu et al. Design and fabrication of electrospun polycaprolactone/chitosan scaffolds for ligament regeneration
Luo et al. Advanced strategies for constructing interfacial tissues of bone and tendon/ligament
CN114504680B (en) Bone-ligament-bone integrated bracket and preparation method thereof
CN113388950A (en) Absorbable high-performance nanofiber woven tendon patch and preparation method thereof
CN110384820A (en) It is a kind of that de- cell tendon line and its construction method is lyophilized
CN211272629U (en) Novel multi-stage structure support
Wu et al. 3D functional scaffolds for tendon tissue engineering
CN110141683A (en) A ligament support, its forming method and ligament implant formed therefrom
Li Electrospinning of core-shell collagen nanofibers
Siridamrong et al. Preparation and Characterization of Polymer Blends from Nang noi srisaket 1 Silk Fibroin, Gelatin and Chitosan Nanofiber Mats Using Formic Acid Solution
Waris et al. Electrospun scaffolds for soft tissue (muscle, fibrous tissue, blood vessels, and supporting tissue) applications
WO2024149413A2 (en) Cylindrical composite nerve scaffold, and preparation method therefor and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190917